Diagnostic value of CD103 expression in bronchoalveolar lymphocytes in sarcoidosis

Summary Background Pulmonary sarcoidosis is frequently characterized by a CD4+ /CD8+ ratio ≥3.5 in bronchoalveolar lavage fluid (BALF), although up to 40% of the cases present a normal or even decreased ratio, pointing out its variability and limitation as a diagnostic marker for sarcoidosis. Lung l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory medicine 2012-07, Vol.106 (7), p.1014-1020
Hauptverfasser: Mota, Patrícia Caetano, Morais, António, Palmares, Carmo, Beltrão, Marília, Melo, Natália, Santos, Ana Cristina, Delgado, Luís
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1020
container_issue 7
container_start_page 1014
container_title Respiratory medicine
container_volume 106
creator Mota, Patrícia Caetano
Morais, António
Palmares, Carmo
Beltrão, Marília
Melo, Natália
Santos, Ana Cristina
Delgado, Luís
description Summary Background Pulmonary sarcoidosis is frequently characterized by a CD4+ /CD8+ ratio ≥3.5 in bronchoalveolar lavage fluid (BALF), although up to 40% of the cases present a normal or even decreased ratio, pointing out its variability and limitation as a diagnostic marker for sarcoidosis. Lung lymphocytes within the bronchial epithelium, the alveolar walls, and BALF express the integrin CD103. Our aim was to compare the expression of CD103 in BALF T-lymphocytes between sarcoidosis and other interstitial lung diseases (ILD) and to evaluate its relevance as a BALF diagnostic marker for sarcoidosis. Methods A total of 86 patients with ILD (mean age ± standard deviation, 42.6 ± 16.6 years; 60.5% female), who underwent BALF as part of their initial diagnostic work-up, were enrolled into 2 groups: sarcoidosis ( n  = 41) and other ILD ( n  = 45). Area under the receiver operating characteristic (ROC) curve (AUC) was used to describe the performance of CD103 for sarcoidosis diagnosis. Results Sarcoidosis patients presented a significantly reduced CD103 expression in BALF T-lymphocytes, more pronounced in the CD4+ subset. The BALF CD103+ CD4+ /CD4+ ratio for a cutoff point of 0.45 was associated with a better diagnostic performance for sarcoidosis (AUC: 0.86 [95% confidence interval (95% CI): 0.78–0.94]; sensitivity: 81%; specificity: 78%), even for those with a CD4+ /CD8+ ratio
doi_str_mv 10.1016/j.rmed.2012.03.020
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1464499133</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0954611112001308</els_id><sourcerecordid>1013918691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c546t-92a5a297d73515f7a7f0fd3da8788b1adf542ab7a19e6d9a12b89beaff8306803</originalsourceid><addsrcrecordid>eNqFkluLFDEQhYMo7jj6B3yQBhF86Ta37k5ABJn1BguCl-dQna64GXs6s0n34Px708wsC_ugT3mo71Tq1ClCnjNaMcqaN9sq7rCvOGW8oqKinD4gK1YLXgrayIdkRXUty4YxdkGepLSllGop6WNywXktWs3Finy79PBrDGnytjjAMGMRXLG5ZFQU-GcfMSUfxsKPRRfDaK8DDAcMA8RiOO7218EeJ0xLOUG0wfch-fSUPHIwJHx2ftfk58cPPzafy6uvn75s3l-VtpbNVGoONXDd9q2oWe1aaB11vehBtUp1DHpXSw5dC0xj02tgvFO6Q3BOZXuKijV5feq7j-FmxjSZnU8WhwFGDHMyTDZSas2E-D9KmdBMNRlek5f30G2Y45iNZCpPKlra6EzxE2VjSCmiM_vodxCPGVq6NWZrlnDMEo6hwuRwsujFufXcLbVbyW0aGXh1BiBZGFyE0fp0x9VKtVrLzL09cZjXe_AYTbIeR4u9j2gn0wf_7zne3ZPbwY8-__gbj5ju_JqUNeb7ckbLFTFO856oEn8B2uPAlg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1035137069</pqid></control><display><type>article</type><title>Diagnostic value of CD103 expression in bronchoalveolar lymphocytes in sarcoidosis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Mota, Patrícia Caetano ; Morais, António ; Palmares, Carmo ; Beltrão, Marília ; Melo, Natália ; Santos, Ana Cristina ; Delgado, Luís</creator><creatorcontrib>Mota, Patrícia Caetano ; Morais, António ; Palmares, Carmo ; Beltrão, Marília ; Melo, Natália ; Santos, Ana Cristina ; Delgado, Luís</creatorcontrib><description>Summary Background Pulmonary sarcoidosis is frequently characterized by a CD4+ /CD8+ ratio ≥3.5 in bronchoalveolar lavage fluid (BALF), although up to 40% of the cases present a normal or even decreased ratio, pointing out its variability and limitation as a diagnostic marker for sarcoidosis. Lung lymphocytes within the bronchial epithelium, the alveolar walls, and BALF express the integrin CD103. Our aim was to compare the expression of CD103 in BALF T-lymphocytes between sarcoidosis and other interstitial lung diseases (ILD) and to evaluate its relevance as a BALF diagnostic marker for sarcoidosis. Methods A total of 86 patients with ILD (mean age ± standard deviation, 42.6 ± 16.6 years; 60.5% female), who underwent BALF as part of their initial diagnostic work-up, were enrolled into 2 groups: sarcoidosis ( n  = 41) and other ILD ( n  = 45). Area under the receiver operating characteristic (ROC) curve (AUC) was used to describe the performance of CD103 for sarcoidosis diagnosis. Results Sarcoidosis patients presented a significantly reduced CD103 expression in BALF T-lymphocytes, more pronounced in the CD4+ subset. The BALF CD103+ CD4+ /CD4+ ratio for a cutoff point of 0.45 was associated with a better diagnostic performance for sarcoidosis (AUC: 0.86 [95% confidence interval (95% CI): 0.78–0.94]; sensitivity: 81%; specificity: 78%), even for those with a CD4+ /CD8+ ratio &lt;3.5 (AUC: 0.79 [95% CI: 0.64–0.93]; sensitivity: 75%; specificity: 78%). Conclusions Assessment of CD103 expression in BALF CD4+ T-lymphocytes may be a reliable tool for sarcoidosis diagnosis, independently of CD4+ /CD8+ ratio, pointing out the relevance of evaluating the CD103+ CD4+ /CD4+ ratio in the ILD diagnostic work-up.</description><identifier>ISSN: 0954-6111</identifier><identifier>EISSN: 1532-3064</identifier><identifier>DOI: 10.1016/j.rmed.2012.03.020</identifier><identifier>PMID: 22537923</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Adult ; Alveoli ; Antigens, CD - metabolism ; Biological and medical sciences ; Biomarkers - metabolism ; Bronchoalveolar lavage fluid ; Bronchoalveolar Lavage Fluid - chemistry ; Bronchoalveolar Lavage Fluid - cytology ; Case-Control Studies ; CD103 ; CD4-CD8 Ratio ; CD4-Positive T-Lymphocytes - metabolism ; CD8-Positive T-Lymphocytes - metabolism ; Comparative analysis ; Confidence intervals ; Disease ; Female ; Humans ; Integrin alpha Chains - metabolism ; Lung diseases ; Lungs ; Lymphocytes ; Male ; Medical sciences ; Middle Aged ; Pneumology ; Pulmonary/Respiratory ; ROC Curve ; Sarcoidosis ; Sarcoidosis, Pulmonary - diagnosis ; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis ; Sensitivity analysis ; Sensitivity and Specificity</subject><ispartof>Respiratory medicine, 2012-07, Vol.106 (7), p.1014-1020</ispartof><rights>Elsevier Ltd</rights><rights>2012 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c546t-92a5a297d73515f7a7f0fd3da8788b1adf542ab7a19e6d9a12b89beaff8306803</citedby><cites>FETCH-LOGICAL-c546t-92a5a297d73515f7a7f0fd3da8788b1adf542ab7a19e6d9a12b89beaff8306803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0954611112001308$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25887994$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22537923$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mota, Patrícia Caetano</creatorcontrib><creatorcontrib>Morais, António</creatorcontrib><creatorcontrib>Palmares, Carmo</creatorcontrib><creatorcontrib>Beltrão, Marília</creatorcontrib><creatorcontrib>Melo, Natália</creatorcontrib><creatorcontrib>Santos, Ana Cristina</creatorcontrib><creatorcontrib>Delgado, Luís</creatorcontrib><title>Diagnostic value of CD103 expression in bronchoalveolar lymphocytes in sarcoidosis</title><title>Respiratory medicine</title><addtitle>Respir Med</addtitle><description>Summary Background Pulmonary sarcoidosis is frequently characterized by a CD4+ /CD8+ ratio ≥3.5 in bronchoalveolar lavage fluid (BALF), although up to 40% of the cases present a normal or even decreased ratio, pointing out its variability and limitation as a diagnostic marker for sarcoidosis. Lung lymphocytes within the bronchial epithelium, the alveolar walls, and BALF express the integrin CD103. Our aim was to compare the expression of CD103 in BALF T-lymphocytes between sarcoidosis and other interstitial lung diseases (ILD) and to evaluate its relevance as a BALF diagnostic marker for sarcoidosis. Methods A total of 86 patients with ILD (mean age ± standard deviation, 42.6 ± 16.6 years; 60.5% female), who underwent BALF as part of their initial diagnostic work-up, were enrolled into 2 groups: sarcoidosis ( n  = 41) and other ILD ( n  = 45). Area under the receiver operating characteristic (ROC) curve (AUC) was used to describe the performance of CD103 for sarcoidosis diagnosis. Results Sarcoidosis patients presented a significantly reduced CD103 expression in BALF T-lymphocytes, more pronounced in the CD4+ subset. The BALF CD103+ CD4+ /CD4+ ratio for a cutoff point of 0.45 was associated with a better diagnostic performance for sarcoidosis (AUC: 0.86 [95% confidence interval (95% CI): 0.78–0.94]; sensitivity: 81%; specificity: 78%), even for those with a CD4+ /CD8+ ratio &lt;3.5 (AUC: 0.79 [95% CI: 0.64–0.93]; sensitivity: 75%; specificity: 78%). Conclusions Assessment of CD103 expression in BALF CD4+ T-lymphocytes may be a reliable tool for sarcoidosis diagnosis, independently of CD4+ /CD8+ ratio, pointing out the relevance of evaluating the CD103+ CD4+ /CD4+ ratio in the ILD diagnostic work-up.</description><subject>Adult</subject><subject>Alveoli</subject><subject>Antigens, CD - metabolism</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - metabolism</subject><subject>Bronchoalveolar lavage fluid</subject><subject>Bronchoalveolar Lavage Fluid - chemistry</subject><subject>Bronchoalveolar Lavage Fluid - cytology</subject><subject>Case-Control Studies</subject><subject>CD103</subject><subject>CD4-CD8 Ratio</subject><subject>CD4-Positive T-Lymphocytes - metabolism</subject><subject>CD8-Positive T-Lymphocytes - metabolism</subject><subject>Comparative analysis</subject><subject>Confidence intervals</subject><subject>Disease</subject><subject>Female</subject><subject>Humans</subject><subject>Integrin alpha Chains - metabolism</subject><subject>Lung diseases</subject><subject>Lungs</subject><subject>Lymphocytes</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pneumology</subject><subject>Pulmonary/Respiratory</subject><subject>ROC Curve</subject><subject>Sarcoidosis</subject><subject>Sarcoidosis, Pulmonary - diagnosis</subject><subject>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><subject>Sensitivity analysis</subject><subject>Sensitivity and Specificity</subject><issn>0954-6111</issn><issn>1532-3064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkluLFDEQhYMo7jj6B3yQBhF86Ta37k5ABJn1BguCl-dQna64GXs6s0n34Px708wsC_ugT3mo71Tq1ClCnjNaMcqaN9sq7rCvOGW8oqKinD4gK1YLXgrayIdkRXUty4YxdkGepLSllGop6WNywXktWs3Finy79PBrDGnytjjAMGMRXLG5ZFQU-GcfMSUfxsKPRRfDaK8DDAcMA8RiOO7218EeJ0xLOUG0wfch-fSUPHIwJHx2ftfk58cPPzafy6uvn75s3l-VtpbNVGoONXDd9q2oWe1aaB11vehBtUp1DHpXSw5dC0xj02tgvFO6Q3BOZXuKijV5feq7j-FmxjSZnU8WhwFGDHMyTDZSas2E-D9KmdBMNRlek5f30G2Y45iNZCpPKlra6EzxE2VjSCmiM_vodxCPGVq6NWZrlnDMEo6hwuRwsujFufXcLbVbyW0aGXh1BiBZGFyE0fp0x9VKtVrLzL09cZjXe_AYTbIeR4u9j2gn0wf_7zne3ZPbwY8-__gbj5ju_JqUNeb7ckbLFTFO856oEn8B2uPAlg</recordid><startdate>20120701</startdate><enddate>20120701</enddate><creator>Mota, Patrícia Caetano</creator><creator>Morais, António</creator><creator>Palmares, Carmo</creator><creator>Beltrão, Marília</creator><creator>Melo, Natália</creator><creator>Santos, Ana Cristina</creator><creator>Delgado, Luís</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>ASE</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>7T5</scope></search><sort><creationdate>20120701</creationdate><title>Diagnostic value of CD103 expression in bronchoalveolar lymphocytes in sarcoidosis</title><author>Mota, Patrícia Caetano ; Morais, António ; Palmares, Carmo ; Beltrão, Marília ; Melo, Natália ; Santos, Ana Cristina ; Delgado, Luís</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c546t-92a5a297d73515f7a7f0fd3da8788b1adf542ab7a19e6d9a12b89beaff8306803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Alveoli</topic><topic>Antigens, CD - metabolism</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - metabolism</topic><topic>Bronchoalveolar lavage fluid</topic><topic>Bronchoalveolar Lavage Fluid - chemistry</topic><topic>Bronchoalveolar Lavage Fluid - cytology</topic><topic>Case-Control Studies</topic><topic>CD103</topic><topic>CD4-CD8 Ratio</topic><topic>CD4-Positive T-Lymphocytes - metabolism</topic><topic>CD8-Positive T-Lymphocytes - metabolism</topic><topic>Comparative analysis</topic><topic>Confidence intervals</topic><topic>Disease</topic><topic>Female</topic><topic>Humans</topic><topic>Integrin alpha Chains - metabolism</topic><topic>Lung diseases</topic><topic>Lungs</topic><topic>Lymphocytes</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pneumology</topic><topic>Pulmonary/Respiratory</topic><topic>ROC Curve</topic><topic>Sarcoidosis</topic><topic>Sarcoidosis, Pulmonary - diagnosis</topic><topic>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</topic><topic>Sensitivity analysis</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mota, Patrícia Caetano</creatorcontrib><creatorcontrib>Morais, António</creatorcontrib><creatorcontrib>Palmares, Carmo</creatorcontrib><creatorcontrib>Beltrão, Marília</creatorcontrib><creatorcontrib>Melo, Natália</creatorcontrib><creatorcontrib>Santos, Ana Cristina</creatorcontrib><creatorcontrib>Delgado, Luís</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><jtitle>Respiratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mota, Patrícia Caetano</au><au>Morais, António</au><au>Palmares, Carmo</au><au>Beltrão, Marília</au><au>Melo, Natália</au><au>Santos, Ana Cristina</au><au>Delgado, Luís</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic value of CD103 expression in bronchoalveolar lymphocytes in sarcoidosis</atitle><jtitle>Respiratory medicine</jtitle><addtitle>Respir Med</addtitle><date>2012-07-01</date><risdate>2012</risdate><volume>106</volume><issue>7</issue><spage>1014</spage><epage>1020</epage><pages>1014-1020</pages><issn>0954-6111</issn><eissn>1532-3064</eissn><abstract>Summary Background Pulmonary sarcoidosis is frequently characterized by a CD4+ /CD8+ ratio ≥3.5 in bronchoalveolar lavage fluid (BALF), although up to 40% of the cases present a normal or even decreased ratio, pointing out its variability and limitation as a diagnostic marker for sarcoidosis. Lung lymphocytes within the bronchial epithelium, the alveolar walls, and BALF express the integrin CD103. Our aim was to compare the expression of CD103 in BALF T-lymphocytes between sarcoidosis and other interstitial lung diseases (ILD) and to evaluate its relevance as a BALF diagnostic marker for sarcoidosis. Methods A total of 86 patients with ILD (mean age ± standard deviation, 42.6 ± 16.6 years; 60.5% female), who underwent BALF as part of their initial diagnostic work-up, were enrolled into 2 groups: sarcoidosis ( n  = 41) and other ILD ( n  = 45). Area under the receiver operating characteristic (ROC) curve (AUC) was used to describe the performance of CD103 for sarcoidosis diagnosis. Results Sarcoidosis patients presented a significantly reduced CD103 expression in BALF T-lymphocytes, more pronounced in the CD4+ subset. The BALF CD103+ CD4+ /CD4+ ratio for a cutoff point of 0.45 was associated with a better diagnostic performance for sarcoidosis (AUC: 0.86 [95% confidence interval (95% CI): 0.78–0.94]; sensitivity: 81%; specificity: 78%), even for those with a CD4+ /CD8+ ratio &lt;3.5 (AUC: 0.79 [95% CI: 0.64–0.93]; sensitivity: 75%; specificity: 78%). Conclusions Assessment of CD103 expression in BALF CD4+ T-lymphocytes may be a reliable tool for sarcoidosis diagnosis, independently of CD4+ /CD8+ ratio, pointing out the relevance of evaluating the CD103+ CD4+ /CD4+ ratio in the ILD diagnostic work-up.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>22537923</pmid><doi>10.1016/j.rmed.2012.03.020</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0954-6111
ispartof Respiratory medicine, 2012-07, Vol.106 (7), p.1014-1020
issn 0954-6111
1532-3064
language eng
recordid cdi_proquest_miscellaneous_1464499133
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adult
Alveoli
Antigens, CD - metabolism
Biological and medical sciences
Biomarkers - metabolism
Bronchoalveolar lavage fluid
Bronchoalveolar Lavage Fluid - chemistry
Bronchoalveolar Lavage Fluid - cytology
Case-Control Studies
CD103
CD4-CD8 Ratio
CD4-Positive T-Lymphocytes - metabolism
CD8-Positive T-Lymphocytes - metabolism
Comparative analysis
Confidence intervals
Disease
Female
Humans
Integrin alpha Chains - metabolism
Lung diseases
Lungs
Lymphocytes
Male
Medical sciences
Middle Aged
Pneumology
Pulmonary/Respiratory
ROC Curve
Sarcoidosis
Sarcoidosis, Pulmonary - diagnosis
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Sensitivity analysis
Sensitivity and Specificity
title Diagnostic value of CD103 expression in bronchoalveolar lymphocytes in sarcoidosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T08%3A58%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20value%20of%20CD103%20expression%20in%20bronchoalveolar%20lymphocytes%20in%20sarcoidosis&rft.jtitle=Respiratory%20medicine&rft.au=Mota,%20Patr%C3%ADcia%20Caetano&rft.date=2012-07-01&rft.volume=106&rft.issue=7&rft.spage=1014&rft.epage=1020&rft.pages=1014-1020&rft.issn=0954-6111&rft.eissn=1532-3064&rft_id=info:doi/10.1016/j.rmed.2012.03.020&rft_dat=%3Cproquest_cross%3E1013918691%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1035137069&rft_id=info:pmid/22537923&rft_els_id=S0954611112001308&rfr_iscdi=true